J.P. Morgan is out with its report today on Mettler-Toledo MTD, maintaining Neutral.
In its report, J.P. Morgan writes, "With shares now trading 19x forward P/E, we see the risk-reward as balanced and remain Neutral. Our December 2011 price target to $170 is based on a 19x multiple to our 2012 EPS estimate of $9.00, a premium to life science tool and industrial comps, but one we view as warranted, given the superior track record of execution and above-average growth rate."
Shares of MTD closed Monday at $148.02, down 4.39% from Friday's close.
Market News and Data brought to you by Benzinga APIs© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
---|
Posted In:
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in